-
China deepens comprehensive reform to strengthen drug, medical device regulation
2025-01-06
China has issued a guideline on comprehensively deepening the reform of regulation of drugs and medical devices to promote the high-quality development of the pharmaceutical industry.
-
1st stem cell therapy, new HIV drug approved
2025-01-06
China's top drug regulator has recently approved the nation's first stem cell therapy to treat a type of complication associated with bone marrow transplant, as well as a novel HIV drug that only requires two shots yearly.
-
Xu Jinghe attends Global Harmonization Working Party annual meeting
2024-12-23
Xu Jinghe, deputy commissioner of China's National Medical Products Administration, attended the 28th annual meeting of the Global Harmonization Working Party (GHWP) and the 28th GHWP Technical Committee Meeting, which were held in Kuala Lumpur, capital of Malaysia, from Dec 9 to 12.
-
NMPA to enhance cooperation with drug regulatory authorities of Vietnam, Thailand
2024-11-22
Li Li, commissioner of China's National Medical Products Administration (NMPA), led a delegation to visit Vietnam and Thailand from Nov 11 to 15 to discuss practical cooperation in drug regulation with related departments.
-
Experts stress good personal hygiene, vaccination as respiratory illnesses rise
2024-11-22
Since the risk of respiratory infectious disease has increased as temperatures drop, experts emphasized the importance of maintaining good personal hygiene and getting vaccinated promptly.
-
China, Saudi Arabia sign MoU on drug regulation
2024-11-12
Li Li, commissioner of China's National Medical Products Administration (NMPA), signed a memorandum of understanding (MoU) on cooperation with Hisham S Aljadhey, chief executive officer of the Saudi Food and Drug Authority (SFDA), on Nov 1 in Beijing, to further enhance bilateral exchanges and cooperation in drug regulation.
